Get startedLog in
    Picture of Bayer AG logo

    BAYN — Bayer AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: FDA Grants Accelerated Approval To Sevabertinib For A Type Of Non-Small Cell Lung Cancer

    Picture of Bayer AG logoBayer AG
    09/09/2026 16:50
    BRIEF-FDA Grants Accelerated Approval To Sevabertinib For A Type Of Non-Small Cell Lung Cancer
    Sept 9 (Reuters) - FDA:
    • FDA : GRANTS ACCELERATED APPROVAL TO SEVABERTINIB FOR LOCALLY ADVANCED/METASTATIC NON-SQUAMOUS NSCLC - STATEMENT
    Further company coverage: [BAYGn.DE]

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Bayer AG

    See all news